D. Calverley

发表

Significant Downregulation of Platelet Gene Expression in Metastatic Lung Cancer

M. Weyant, T. Phang, B. Gao, 2010, Clinical and translational science.

Bleeding and Thrombosis in Cancer Patients

T. Deloughery, D. Calverley, 2015 .

ANTIPLATELET THERAPY: Aspirin, Ticlopidine/Clopidogrel, and Anti-Integrin Agents

G. Roth, D. Calverley, David C. Calverley, 1998 .

Antiplatelet therapy in the elderly. Aspirin, ticlopidine-clopidogrel, and GPIIb/GPIIIa antagonists.

D. Calverley, David C. Calverley, 2001, Clinics in geriatric medicine.

Association between monocyte Fcγ subclass expression and acute coronary syndrome

S. Groshen, T. Buchanan, W. Mack, 2001, Immunity & Ageing.

Platelet FcγRIIA expression is associated with the α2 integrin C807T gene polymorphism in type 2 diabetes

K. McFann, D. Calverley, Lyndy V Baldermann, 2006 .

Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.

B. Munt, A. Chalmers, J. Wade, 1992, The Journal of rheumatology.

Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus

S. Groshen, T. Buchanan, M. Hacker, 2003, British journal of haematology.

Human signaling protein 14-3-3zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta.

T. Kavanagh, G. Roth, D. Calverley, 1998, Blood.

Aspirin, platelets, and thrombosis: theory and practice

G. Roth, D. Calverley, 1994 .

Aspirin, platelets, and thrombosis: theory and practice.

G. Roth, D. Calverley, Gerald, 1994, Blood.

Splenic radiation for corticosteroid-resistant immune thrombocytopenia.

J. Kelton, D. Calverley, G. Jones, 1992, Annals of internal medicine.

Platelet Gene Expression as a Biomarker Risk Stratification Tool in Acute Myocardial Infarction: A Pilot Investigation

J. Messenger, T. Phang, B. Gao, 2010 .

Increased platelet Fc receptor expression in diabetes is limited to those with type 2 disease and low LDL cholesterol levels.

J. Hokanson, G. Kinney, D. Calverley, 2006, Atherosclerosis.

A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.

P. Gottlieb, A. Putnam, D. Wagner, 2007, Clinical immunology.

Red blood cell alloimmunization in transfused patients on AZT

P. Ballem, L. Haley, D. Calverley, 1991, British journal of haematology.

PLATELET FUNCTION: PHARMACOLOGY AND THROMBOSIS PREVENTION

G. Roth, D. Calverley, 1999 .

Human platelet glycoprotein V: its role in enhancing expression of the glycoprotein Ib receptor.

S. Stray, G. Roth, D. Calverley, 1995, Blood.

Mast cell disease associated with acute myeloid leukemia: Detection of a new c‐kit mutation Asp816His

R. Brynes, V. Pullarkat, D. Calverley, 2000, American journal of hematology.

Validation of a method for quantifying carotid artery calcification from panoramic radiographs.

J. Hokanson, G. Grunwald, D. Lezotte, 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis.

S. Groshen, H. Hodis, V. Pullarkat, 2002, Atherosclerosis.

Human Signaling Protein 14-3-3ζ Interacts With Platelet Glycoprotein Ib Subunits Ibα and Ibβ

T. Kavanagh, G. Roth, D. Calverley, 1998 .

Aspirin, Prostaglandins and Platelet Function: Pharmacology and Thrombosis Prevention

G. Roth, D. Calverley, 1999 .

Aspirin, Ticlopidine/Clopidogrel, and Anti-Integrin Agents

G. Roth, D. Calverley, 1998 .

A unique Tcell subset described as CD4 lo CD40 + Tcells (T CD40 ) in human type 1 diabetes

P. Gottlieb, A. Putnam, D. Wagner, 2007 .

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

B. Gage, K. Carson, N. Kuderer, 2019, American journal of hematology.

Diagnostic capabilities of fractal dimension and mandibular cortical width to identify men and women with decreased bone mineral density

J. Hokanson, G. Grunwald, D. Lezotte, 2012, Osteoporosis International.

Thrombocytopenia caused by immunologic platelet destruction

M. Recht, D. Calverley, K. Haley, 2013 .

Thromboembolic risk in patients with lung cancer receiving systemic therapy

Reid F Thompson, K. Gundle, M. Conlin, 2021, British journal of haematology.

Thromboembolic risk in lung cancer patients receiving systemic therapy

K. Gundle, M. Conlin, R. Thompson, 2020, medRxiv.

Loss of alveolar bone due to periodontal disease exhibits a threshold on the association with coronary heart disease.

J. Hokanson, G. Grunwald, D. Lezotte, 2011, Journal of periodontology.

The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971-1988.

J. Hay, D. Calverley, A. Flores, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Risk of Venous Thromboembolism in Multiple Myeloma: Identification of Risk Factor

B. Gage, K. Carson, K. Sanfilippo, 2016 .

Predictive ability of the khorana score for venous thromboembolism (VTE) in multiple myeloma (MM).

B. Gage, K. Carson, N. Kuderer, 2018 .

Chronic lymphocytic leukemia/small lymphocytic lymphoma presenting in urinary bladder without peripheral blood lymphocytosis: Case report and literature review

D. Calverley, P. Shen, John D Carver, 2006, Leukemia and Lymphoma.

Characterization of a highly polymorphic trinucleotide short tandem repeat within the human antithrombin gene.

M. Blajchman, R. Austin, B. Eng, 1994, Thrombosis research.

Platelet FcgammaRIIA receptor surface expression is increased in patients with ESRD and is associated with atherosclerotic cardiovascular events.

W. Mack, M. Noureddin, M. El-Shahawy, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association between monocyte Fcγ subclass expression and acute coronary syndrome

S. Groshen, T. Buchanan, W. Mack, 2001, Immunity & Ageing.